Pancreatic Cancer Research

ResearcherKansas State UniversityActive in the last 2 years

Matthew T. Basel

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2729-7428; OpenAlex author ID A5037856912. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2012: 2 papers · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper

Papers 4

  1. Thermosensitive Liposomes for Gemcitabine Delivery to Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/cancers16173048↗
  2. In Vitro Measurement and Mathematical Modeling of Thermally-Induced Injury in Pancreatic Cancer Cells. Co-author DOI 10.3390/cancers15030655↗
  3. A cell-delivered and cell-activated SN38-dextran prodrug increases survival in a murine disseminated pancreatic cancer model. Co-author DOI 10.1002/smll.201101879↗
  4. Cell-delivered magnetic nanoparticles caused hyperthermia-mediated increased survival in a murine pancreatic cancer model. Co-author DOI 10.2147/ijn.s28344↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Cesar B. Aparicio-Lopez · 1 shared paper, 2024 · strength 0.24
  2. Stefan H. Bossmann · 2 shared papers, 2012–2023 · strength 0.23
  3. Faraz Chamani · 1 shared paper, 2023 · strength 0.19
  4. Punit Prakash · 1 shared paper, 2023 · strength 0.19
  5. Masaaki Tamura · 2 shared papers, 2012 · strength 0.06
  6. Deryl L. Troyer · 1 shared paper, 2012 · strength 0.03
  7. Troyer · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.